Aethlon Medical INC Form 4 insider transactions

NASDAQ
Director Edward G. Broenniman forfeited 1,645 shares of Aethlon Medical common stock to cover tax obligations upon conversion of restricted stock units.
NASDAQ
Director Chetan Shah forfeited 3,289 shares of Aethlon Medical common stock to cover tax obligations upon the conversion of restricted stock units.
NASDAQ
Director Chetan Shah disposed of 3,289 shares of Aethlon Medical Inc. to cover tax obligations related to the vesting of restricted stock units.
NASDAQ
Director Nicolas Gikakis sold 5,244 shares of Aethlon Medical Inc. to cover tax obligations related to the vesting of restricted stock units.
NASDAQ
Director Edward Broenniman disposed of 1,645 shares of Aethlon Medical Inc. to cover tax obligations related to the vesting of restricted stock units.
NASDAQ
Director Edward Broenniman reports acquisition and disposal of Aethlon Medical (AEMD) common stock and vesting of RSUs.
NASDAQ
Director Angela Rossetti reports acquiring 32,894 shares of Aethlon Medical, Inc. common stock on April 16, 2024.
NASDAQ
Director Chetan Shah reports acquiring 32,894 shares of Aethlon Medical common stock at $1.52 per share and disposing of 44,532 shares.
NASDAQ
Director Nicolas Gikakis reported acquiring 32,894 shares of Aethlon Medical at $1.52 and vesting of restricted stock units (RSUs).
NASDAQ
Director Nicolas Gikakis sold 1,954 shares of Aethlon Medical Inc. to cover tax obligations arising from the vesting of restricted stock units.
NASDAQ
Director Edward Broenniman reports the disposal of 1,163 common stock shares of Aethlon Medical Inc. to cover tax obligations upon vesting of a restricted stock unit (RSU).
NASDAQ
Director Chetan Shah disposed of 1,163 shares of Aethlon Medical Inc. to cover tax obligations related to the vesting of restricted stock units.